These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31443887)

  • 1. A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder.
    Uebelacker LA; Van Noppen D; Tremont G; Bailey G; Abrantes A; Stein M
    J Subst Abuse Treat; 2019 Oct; 105():19-27. PubMed ID: 31443887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR; Darnall BD; You DS
    JMIR Res Protoc; 2024 Jun; 13():e53784. PubMed ID: 38843513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intervention components to maximize yoga practice among people with chronic pain taking opioid agonist therapy: A factorial experiment using the multiphase optimization strategy framework.
    Uebelacker LA; Braun TD; Taylor LE; Saper R; Baldwi M; Abrantes A; Tremont G; Toribio A; Kirshy S; Koch R; Lorin L; Van Noppen D; Anderson B; Roseen EJ; Stein MD
    Contemp Clin Trials; 2024 Feb; 137():107411. PubMed ID: 38103784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain.
    Barry DT; Beitel M; Cutter CJ; Fiellin DA; Kerns RD; Moore BA; Oberleitner L; Madden LM; Liong C; Ginn J; Schottenfeld RS
    Drug Alcohol Depend; 2019 Jan; 194():460-467. PubMed ID: 30508769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
    Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Edwards RR; Samet JH
    Drug Alcohol Depend; 2016 Sep; 166():26-31. PubMed ID: 27422763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, Validation, and Feasibility Testing of a Yoga Module for Opioid Use Disorder.
    Bhargav H; Vidyasagar PD; Venugopal S; Arsappa R; Narasimha VL; Varshney P; Sharma P; A V; Venkatasubramanian G; Varambally S; Gangadhar BN; Murthy P
    Adv Mind Body Med; 2021 Summer; 35(3):20-30. PubMed ID: 34237026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.
    Jutras-Aswad D; Le Foll B; Ahamad K; Lim R; Bruneau J; Fischer B; Rehm J; Wild TC; Wood E; Brissette S; Gagnon L; Fikowski J; Ledjiar O; Masse B; Socias ME;
    Am J Psychiatry; 2022 Oct; 179(10):726-739. PubMed ID: 35702828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.
    Cooperman NA; Hanley AW; Kline A; Garland EL
    J Subst Abuse Treat; 2021 Aug; 127():108468. PubMed ID: 34134880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of a yoga intervention to decrease pain in older women: a randomized controlled pilot study.
    Seguin-Fowler R; Graham M; Ward J; Eldridge G; Sriram U; Fine D
    BMC Geriatr; 2020 Oct; 20(1):400. PubMed ID: 33046009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results.
    MacLean RR; Heapy AA; Waters AJ; Wolkowicz N; Szollosy SK; Meyerovich J; Sofuoglu M
    Drug Alcohol Depend; 2023 May; 246():109857. PubMed ID: 37004461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
    Benville JR; Compton P; Giordano NA; Cheatle MD
    Drug Alcohol Depend; 2021 Apr; 221():108619. PubMed ID: 33667781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.
    Gomes T; McCormack D; Bozinoff N; Tadrous M; Antoniou T; Munro C; Campbell T; Paterson JM; Mamdani M; Sproule B
    Addiction; 2022 Jul; 117(7):1972-1981. PubMed ID: 35257434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.
    Dunn KE; Finan PH; Tompkins DA; Fingerhood M; Strain EC
    Drug Alcohol Depend; 2015 Dec; 157():143-9. PubMed ID: 26518253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
    Neumann AM; Blondell RD; Jaanimägi U; Giambrone AK; Homish GG; Lozano JR; Kowalik U; Azadfard M
    J Addict Dis; 2013; 32(1):68-78. PubMed ID: 23480249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
    Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
    Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
    Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
    Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.
    Sigmon SC; C Meyer A; Hruska B; Ochalek T; Rose G; Badger GJ; Brooklyn JR; Heil SH; Higgins ST; Moore BA; Schwartz RP
    Addict Behav; 2015 Dec; 51():136-42. PubMed ID: 26256469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.
    Wu LT; John WS; Morse ED; Adkins S; Pippin J; Brooner RK; Schwartz RP
    Addiction; 2022 Feb; 117(2):444-456. PubMed ID: 34286886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.